<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/92064AFF-7AF9-4899-B8E8-BF602C8F2623"><gtr:id>92064AFF-7AF9-4899-B8E8-BF602C8F2623</gtr:id><gtr:name>Lonza Biologics Plc</gtr:name><gtr:address><gtr:line1>228 BATH ROAD , SLOUGH</gtr:line1><gtr:city>BERKSHIRE</gtr:city><gtr:postCode>SL1 4DX</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/92064AFF-7AF9-4899-B8E8-BF602C8F2623" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>92064AFF-7AF9-4899-B8E8-BF602C8F2623</gtr:id><gtr:name>Lonza Biologics Plc</gtr:name><gtr:address><gtr:line1>228 BATH ROAD , SLOUGH</gtr:line1><gtr:city>BERKSHIRE</gtr:city><gtr:postCode>SL1 4DX</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>226876.0</gtr:offerGrant><gtr:projectCost>453751.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2463F4CE-AB0E-4BC6-9830-37B8C08541A3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>2463F4CE-AB0E-4BC6-9830-37B8C08541A3</gtr:id><gtr:name>Amercare Limited</gtr:name><gtr:address><gtr:line1>UNIT L HOWLAND ROAD BUSINESS PARK , HOWLAND ROAD</gtr:line1><gtr:city>THAME</gtr:city><gtr:postCode>OX9 3GQ</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>134007.0</gtr:offerGrant><gtr:projectCost>223345.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>0.0</gtr:offerGrant><gtr:projectCost>0.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2D0BEE9E-4DED-4E38-97FF-88FF2D4088B9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>2D0BEE9E-4DED-4E38-97FF-88FF2D4088B9</gtr:id><gtr:name>eXmoor Pharma Concepts Limited</gtr:name><gtr:address><gtr:line1>6th Floor Reading Bridge House
Reading Bridge</gtr:line1><gtr:city>Reading</gtr:city><gtr:postCode>RG1 8LS</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>313179.0</gtr:offerGrant><gtr:projectCost>522401.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6BAA32D3-0592-4662-8707-B8FF49287B99"><gtr:id>6BAA32D3-0592-4662-8707-B8FF49287B99</gtr:id><gtr:firstName>Unknown</gtr:firstName><gtr:otherNames>Unknown</gtr:otherNames><gtr:surname>Unknown</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=101098"><gtr:id>4DDDD1E3-81AD-42D6-87ED-C22DA6E60551</gtr:id><gtr:title>CPrep - Closed point-of-care-Preparation Device</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Collaborative R&amp;D</gtr:grantCategory><gtr:grantReference>101098</gtr:grantReference><gtr:abstractText>This project will establish a world-class consortium to innovatively address a critical step in administering cellular products for the cell therapy industry (CTI) ? a robust validated platform technology to enable post-manufacturing process steps to be carried out at the point of care (PoC). This Closed-point-of-care-Preparation device will increase patient safety and enable a new generation of cell therapies that would otherwise have to be shipped fresh with its inherent logistics problems. This will address every step after a cell therapy leaves the central GMP facility through to the completion of the loading of the clinical implantation device at the PoC. Presently no such integrated closed PoC technology exists. Requirement for such a device is well recognised by CTI.</gtr:abstractText><gtr:fund><gtr:end>2015-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2012-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>674062</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">101098</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>